OS Therapies, Inc. (OSTX) WHO Clears 'Herlystic'; UK Filing Next, Orbis Path Planned

OS Therapies received WHO approval of 'Herlystic' for OST-HER2 and plans to file first with the U.K. MHRA under Project Orbis, followed by FDA, EMA and TGA. FDA BLA is targeted under Accelerated Approval after final 3-year OS data.Material DetailsContext by AI AnalystThis is an early-to-mid regulat…